Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 5 | 2 |
| List of Tables | 6 | 1 |
| List of Figures | 6 | 1 |
| Cosmeceuticals Market to 2018 - Introduction | 7 | 1 |
| Cosmeceuticals Market to 2018 - Overview | 8 | 8 |
| Introduction | 8 | 1 |
| Classification | 8 | 1 |
| Economic Trends | 8 | 1 |
| Common Ingredients in Cosmeceuticals | 8 | 1 |
| Retinoids | 8 | 1 |
| Hydroxy Acids | 8 | 1 |
| Antioxidants | 9 | 1 |
| De-pigmenting Agents | 9 | 1 |
| Botanicals | 9 | 1 |
| Enzymes | 9 | 1 |
| Hormones | 10 | 1 |
| Estrogens | 10 | 1 |
| Progesterone | 10 | 1 |
| Testosterone | 10 | 1 |
| Growth hormone | 10 | 1 |
| Topical Anesthetics and Antipruritics | 10 | 1 |
| Ethyl aminobenzoate | 10 | 1 |
| Benzyl alcohol | 10 | 1 |
| Diperodon hydrochloride | 10 | 1 |
| Pramoxine hydrochloride | 10 | 1 |
| Menthol | 10 | 1 |
| Hair-loss Treatments | 11 | 1 |
| Pinacidil, P-1075, cromakalim, and nicorandil | 11 | 1 |
| Minoxidil | 11 | 1 |
| Cysteine and arginine | 11 | 1 |
| Saw palmetto (Serenoa repens) | 11 | 1 |
| Scar Treatments | 11 | 1 |
| Silicone gel sheeting | 11 | 1 |
| Adhesive microporous hypoallergenic paper tape | 11 | 1 |
| Miscellaneous compounds in scar management | 12 | 1 |
| Safety and Regulation | 13 | 1 |
| Coverage by the US Food and Drug Administration | 13 | 1 |
| Coverage by the US Federal Trade Commission | 13 | 1 |
| Coverage by the European Medicines Agency | 13 | 1 |
| Coverage by Ministry of Health, Labor and Welfare, Japan | 14 | 1 |
| Standards for Natural and Organic Products | 14 | 1 |
| Product Development and Application Technologies | 15 | 1 |
| Cosmeceuticals Market to 2018 - Market Overview | 16 | 11 |
| Market Overview | 16 | 2 |
| Market by Geography | 18 | 1 |
| US | 18 | 1 |
| Top Five European Countries | 19 | 1 |
| Japan | 20 | 1 |
| Market by Channel | 21 | 1 |
| Market Trends | 21 | 1 |
| Demographic Trends | 21 | 1 |
| Demographic Trends Drive Demand for Anti-Aging Skin Care Products | 21 | 2 |
| Growing Influence of Emerging Markets in Asia-Pacific and Other Geographies Powered by Digital Marketing and E-commerce | 23 | 1 |
| Cosmeceutical Treatments and Product Trends | 23 | 1 |
| Persistent Popularity of Anti-Oxidant-Based Skin Care Products | 23 | 1 |
| Increasing Use of Natural and Organic Ingredients | 23 | 1 |
| Professional Skin Care Posted Growth in Developed Markets and is Showing Promise in Emerging Markets | 24 | 1 |
| Increasing Preference for Non-Invasive or Minimally Invasive Cosmetic Procedures | 24 | 1 |
| Industry Trends | 25 | 1 |
| Slow Return to Luxury Spending | 25 | 1 |
| Developing Regional Markets Based on Local Ecosystems | 25 | 1 |
| SWOT Analysis | 26 | 1 |
| Cosmeceuticals Market to 2018 - Market by Category | 27 | 4 |
| Skin Care Cosmeceuticals | 28 | 1 |
| Introduction | 28 | 1 |
| Hair Care Cosmeceuticals | 28 | 1 |
| Introduction | 28 | 1 |
| Cosmeceuticals Market Outlook | 29 | 1 |
| Cosmeceuticals and Premium Pricing | 29 | 1 |
| Consumer Perception | 29 | 1 |
| Cosmeceuticals - A Lucrative Opportunity for Pharmaceutical Companies? | 30 | 1 |
| Cosmeceuticals and Impact of Regulations | 30 | 1 |
| Cosmeceuticals Market to 2018 - Competitive Landscape | 31 | 5 |
| Company Profiles | 31 | 1 |
| Beiersdorf | 31 | 1 |
| Introduction | 31 | 1 |
| Financial Performance | 31 | 1 |
| Colgate-Palmolive | 31 | 1 |
| Introduction | 31 | 1 |
| Financial Performance | 32 | 1 |
| Henkel | 32 | 1 |
| Introduction | 32 | 1 |
| Financial Performance | 32 | 1 |
| Johnson &Johnson | 33 | 1 |
| Introduction | 33 | 1 |
| Financial Performance | 33 | 1 |
| L'Oreal S.A. | 33 | 1 |
| Introduction | 33 | 1 |
| Financial Performance | 34 | 1 |
| Procter &Gamble Company | 34 | 1 |
| Introduction | 34 | 1 |
| Financial Performance | 34 | 1 |
| Unilever | 35 | 1 |
| Introduction | 35 | 1 |
| Financial Performance | 35 | 1 |
| Cosmeceuticals Market to 2018 - Appendix | 36 | 4 |
| Market Definitions | 36 | 1 |
| Abbreviations | 36 | 1 |
| Bibliography | 37 | 1 |
| Research Methodology | 37 | 2 |
| Coverage | 37 | 1 |
| Secondary Research | 38 | 1 |
| Primary Research | 38 | 1 |
| Expert Panel Validation | 38 | 1 |
| Contact Us | 39 | 1 |
| Disclaimer | 39 | 1 |
